Navigation Links
Galderma Launches New Cetaphil(R) SPF 50 Product
Date:2/17/2009

Top Skin Care Brand is Taking Facial Sun Protection to a New Level

FORT WORTH, Texas, Feb. 17 /PRNewswire/ -- Galderma Laboratories is excited to introduce a NEW SPF 50 facial moisturizer from Cetaphil(R), the #1 dermatologist-recommended brand of cleansers and moisturizers, that provides broad spectrum protection. Finally, a product that goes beyond moisturizing, to provide the highest SPF available for a moisturizer designed specifically for the face. Cetaphil(R) UVA/UVB Defense SPF 50 is non-greasy; it nourishes and hydrates skin, while protecting it from the sun's harmful rays.

Cetaphil(R) UVA/UVB Defense SPF 50 delivers across the spectrum to help protect skin from UVA/UVB rays, and help hydrate as a daily facial moisturizer. It contains an optimum blend of 4 filters and micronized Titanium Dioxide that screen both the UVA and UVB rays. For patients requiring an effective sunscreen as part of the management of their skin related condition, Cetaphil(R) UVA/UVB Defense SPF 50 combines two steps in one making it an ideal choice for both daily sun protection and for moisturizing the face.

Cetaphil(R) UVA/UVB Defense SPF 50 has also been awarded the Skin Cancer Foundation Seal of Recommendation. The Skin Cancer Foundation recommends this product as an effective UV facial sunscreen and as an effective aid in the prevention of sun induced damage to the skin including sunburn and possibly, premature aging. It is important to use proper UVA/UVB filters to help prevent sunburn and other skin damage.

The lightweight formula of the Cetaphil(R) UVA/UVB Defense SPF 50 hydrates the skin to avoid evaporation and absorbs quickly, leaving no filmy white residue. It is fragrance free, non-irritating and non-comedogenic, so it won't clog pores, making it a suitable choice for those with acne, rosacea or melasma and other skin related conditions, where a hydrating formula with SPF protection is recommende
'/>"/>

SOURCE Galderma Laboratories
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Galderma Wins FDA Approval for Vectical(TM) Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis
2. Galderma Announces Availability of Epiduo(TM) Gel, the First and Only Combination Treatment with a Retinoid and Benzoyl Peroxide to Treat Acne
3. Galderma announces approval for Differin gel 0.1 percent in Japan
4. Galderma Completes Tender Offer for CollaGenex
5. Galderma Announces HSR Clearance for Its Proposal to Acquire CollaGenex Pharmaceuticals
6. ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic
7. Galderma Pharma, S.A. and ZARS Pharma, Inc. Extend Agreement to Cover Worldwide Rights for Pliaglis(TM)
8. Galderma Reaches Agreement to Acquire CollaGenex Pharmaceuticals
9. Galderma Associates Itself to Cartiers Womens Initiative Awards to Recognize Female Entrepreneurs From Around the Globe
10. Crossover Health Launches Personal Health Advisory Service
11. Photos: Medpedia Launches
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... July 28, 2015 , ... ... that Schneider Electric has completed its upgrade and expansion of its ... with more than 170,000 employees in 134 countries supplying a wide range of ...
(Date:7/28/2015)... ... July 28, 2015 , ... ... biologics and biologic-device combination products for the treatment of bone disorders and conditions ... Patent No. 9,062,300 entitled "Fusion Proteins of Collagen Binding-Domain and Parathyroid Hormone". The ...
(Date:7/28/2015)... ... July 28, 2015 , ... A new Taiwanese study suggests ... are in the general population. Surviving Mesothelioma has just posted an article detailing ... at Taiwan’s National Health Research Institutes and three Taiwanese universities evaluated the health ...
(Date:7/28/2015)... MA (PRWEB) , ... July 28, 2015 , ... Women ... cancer. One reason is that cancer, heart attack, and stroke are treatable, but there ... thing individuals can do is to take part in a clinical trial, reports the ...
(Date:7/28/2015)... ... July 28, 2015 , ... Every summer, the public is reminded ... caution when lighting fireworks in their own neighborhoods. Unfortunately, according to a recent report ... 3, 2015 USA Today article " Eye Injuries Caused by Fireworks Doubled in Last ...
Breaking Medicine News(10 mins):Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 2Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 3Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 4Health News:BiologicsMD, Inc. Announces Additional US Patent Issuance Covering Company’s Pipeline of Targeted Therapies 2Health News:New Findings Suggest Mesothelioma is Not the Only Cancer Threat for Shipbreakers, According to Surviving Mesothelioma 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 2Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 3
... (Jan. 17, 2008) Twenty research projects have been ... at the Argonne Leadership Computing Facility (ALCF) at Argonne ... competitively selected group of 55 scientific projects announced Thursday ... awards are made through the 2008 Innovative and Novel ...
... diagnostic tool to detect surface cancers quickly and ... calculate body composition has been developed by a ... from QUTs School of Physical and Chemical Sciences ... spectroscopy to diagnose cervical and skin cancers. , ...
... stroke and even death, study finds , , FRIDAY, ... to aspirin are four times more likely to suffer a ... says. , People who are aspirin-resistant have platelets -- the ... in the same way as platelets in people who respond ...
... Jan. 18 Cardiac Science,Corporation (Nasdaq: ... cardiac diagnosis,resuscitation, rehabilitation, and informatics products, announced ... its first responder units with,425 Powerheart(R) G3 ... (Logo: http://www.newscom.com/cgi-bin/prnh/20050913/SFTU139LOGO ), "Like first ...
... Farm Safety 4 Just Kids Founder, Adams, Reaches Finals of 6th Annual Volvo ... Celebrity Judges Will Select and Unveil Top Four Winners March 19 at Volvo,for life ... ... Life, IRVINE, Calif., Jan. 18 For the past ...
... Jan. 18 /PRNewswire-FirstCall/ - QLT Inc. (NASDAQ: QLTI;,TSX: ... reduction in its,overall headcount affecting approximately 115 people ... U.S. subsidiaries, including members,of its management team., ... undertaken by the,Company as part of its strategic ...
Cached Medicine News:Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 2Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 3Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 4Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 5Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 6Health News:Argonne's Blue Gene/P to host large cadre of INCITE researchers 7Health News:Cardiac Science Completes Deployment of AEDs With Los Angeles County Fire Department 2Health News:Cardiac Science Completes Deployment of AEDs With Los Angeles County Fire Department 3Health News:America Selects Earlham Resident Marilyn Adams as One of the Nation's Top Hometown Heroes 2Health News:America Selects Earlham Resident Marilyn Adams as One of the Nation's Top Hometown Heroes 3Health News:America Selects Earlham Resident Marilyn Adams as One of the Nation's Top Hometown Heroes 4Health News:America Selects Earlham Resident Marilyn Adams as One of the Nation's Top Hometown Heroes 5Health News:QLT reduces workforce as first step in its strategic restructure 2Health News:QLT reduces workforce as first step in its strategic restructure 3
(Date:7/27/2015)... -- SeraCare Life Sciences, a leading partner to global ... AACC Annual Meeting today that it has signed ... biotechnology company that develops, markets and sells preanalytic ... ViveST™ allow sample collection, transport and storage in ... of the agreement, the two firms will jointly ...
(Date:7/27/2015)... July 27, 2015  The fairness of the proposed ... St. Jude Medical ("St. Jude") is the subject of ... shareholder rights law firm.  The investigation is focusing on ... law by the Board of Directors of THOR for ... July 22, 2015, the Company announced it had reached a ...
(Date:7/27/2015)... , July 20, 2015 ... has announced the addition of the "Cardiometabolic ... Afrezza,s discounted pricing is in line ... is critical to the product,s commercial appeal. However, ... prevent Afrezza from gaining a sizeable share of ...
Breaking Medicine Technology:SeraCare Life Sciences Announces Strategic Partnership with ViveBio to Enable Next Generation Preanalytic Products for the IVD Industry 2SeraCare Life Sciences Announces Strategic Partnership with ViveBio to Enable Next Generation Preanalytic Products for the IVD Industry 3WeissLaw LLP: Thoratec Corporation Acquisition By St. Jude Medical May Not Be In The Best Interest Of THOR Shareholders 2Cardiometabolic Drug News Issue - Afrezza Aggressive Pricing Strategy View Playing Out 2Cardiometabolic Drug News Issue - Afrezza Aggressive Pricing Strategy View Playing Out 3
... Motion Therapeutics, Inc. http://www.motiontherapeutics.com , the leading provider ... today announced that researchers at Samuel Merritt University and ... to study the effects of wearing a strategically weighted ... MS. This grant comes after the ...
... Argon Medical Devices, Inc. announced today that it ... LP ("Rex Medical") for exclusive global rights to market and ... device used in the prevention of Pulmonary Embolism (PE). ... to our product portfolio. This proven technology has rapidly become ...
Cached Medicine Technology:The Balance-Based Torso-Weighting® Treatment for Multiple Sclerosis Receives a NIH Recovery Act Grant 2Argon Medical Devices Announces Exclusive License and Distribution Agreement for Option™ Retrievable Inferior Vena Cava Filter 2Argon Medical Devices Announces Exclusive License and Distribution Agreement for Option™ Retrievable Inferior Vena Cava Filter 3
The ultimate ultrasound system for clinical ophthalmologists....
The Ultrasonic BioMicroscope (UBM P40) provides the highest ultrasound resolution for imaging....
EchoScan US-3300 takes accurate axial length and corneal thickness measurements in either automatic or manual modes. It is available in a single configuration or in combination with the A scan for ma...
... eye. Whether used as part of ... independently to accommodate a specific scanning ... to accommodate maximizing the image resolution. ... tonometer-mounted, hand-held and immersion techniques. Unique ...
Medicine Products: